Accurately determining the sheer commercial scale of diagnostic needs is the cornerstone of strategy in the US healthcare landscape. The US HIV Diagnostics Market Size is a function of the total number of tests performed annually—encompassing mandated blood bank screenings, routine clinical check-ups, targeted testing for high-risk populations, and the burgeoning volume of at-home...